True degenerative aneurysms of permanent vascular access. Etiology, pathogenesis and clinical characteristics of patients

Abstract

Background. The frequency of development of true aneurysms of native permanent vascular access according to the literature ranges from 5 to 40% of patients on program hemodialysis. Current clinical guidelines contain neither a clear definition of this notion nor specific treatment algorithms for this pathology.

Objective. The purpose of this study was to determine the prevalence of true degenerative aneurysms of a permanent vascular access (PVA), possible etiologic factors of their occurrence, clinical peculiarities of the course of the disease, and the most significant syndromes in this pathology of PVA.

Patients and methods. The study included a total of 219 patients undergoing program dialysis through a native arteriovenous fistula. The patients’ age ranged from 24 to 83 years (mean 59.1±0.9 years). There were 114 males and 105 females. The mean time on program hemodialysis was 60.7±3.9 (1–360) months. The average duration of the relevant vascular access functioning amounted to 45.3±3.1 months (1–312). An “aneurysm of the permanent vascular access” was defined as the size of the native vascular access exceeding 2.0 cm, i. e., a twofold increase in the median diameter of the arteriovenous fistula (AVF) in the study group (1.0).

Results and discussion. Aneurysms of the native permanent vascular access were detected in 11.8% of patients. No correlation between the frequency of aneurysm development and hereditary pathology was revealed. 54.5% of the patients diagnosed with PVA aneurysms had pathology of outflow tracts, with a peculiarity that catheterization of homolateral central veins was recorded 2.1 times more often in their medical histories. The duration of AVF function without aneurysms was 2.7 times shorter than in the group with aneurysms (36±3.9 vs. 96±9.7 months, p=0.000).

Volumetric blood flow through the AVF (QA AVF, ml/min) was 1.7 times higher in patients with aneurysms, and shunt cardiac fraction (QA to minute cardiac volume ratio – SCF) was 1.8 times higher (p<0.05). Abnormal SCF (greater than 0.3) was present in 80.0% of patients with aneurysms and only in 15.7% of patients without aneurysms (p<0.001). During a 12-month follow-up, these indices had significant negative dynamics, and the rate of change in these indices had a significant positive correlation with the diameter of the AVF. Progression of high-flow syndrome is associated with potential development of chronic heart failure and may be an indication for surgical correction of true degenerative aneurysms of the permanent vascular access.

Conclusion. One of the most significant clinical syndromes accompanying PVA degenerative aneurysms is high AVF flow, potentially leading to heart failure. This pathology progresses over time, and the rate of its development correlates with the diameter of the native AVF.

Funding. The study had no financial support.

Conflict of interest. The authors declare no conflicts of interest.

Authors’ contribution. Study conception and design – Maksimov A.V., Feiskhanov A.K., Grigoryan D.V.; data collection and handling – Maksimov A.V., Grigoryan D.V., Akhundova E.N.; statistical processing – Maksimov A.V., Grigoryan D.V.; draft manuscript preparation – Maksimov A.V., Grigoryan D.V.; manuscript revision – Maksimov A.V., Feiskhanov A.K., Poberezhnyi V.Ya.

For citation: Maksimov A.V., Feiskhanov A.K., Grigoryan D.V., Akhundova E.N., Poberezhnyi V.Ya. True degenerative aneurysms of permanent vascular access. Etiology, pathogenesis and clinical characteristics of patients. Angiology and Vascular Surgery. Journal named after Academician A.V. Pokrovsky. 2024; 30 (2): 72–9. DOI: https://doi.org/10.33029/1027-6661-2024-30-2-72-79

Keywords: program hemodialysis; permanent vascular access; true aneurysms

References

1.Pasklinsky G., Meisner R.J., Labropoulos N., et al. Management of true aneurysms of hemodialysis access fistulas. Journal of Vascular Surgery. 2011; 53 (5): 1291–1297. DOI: https://doi.org/10.1016/j.jvs.2010.11.100

2. Schmidli J., Widmer M. K., Basile C., et al. Vascular Access: 2018 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). European Journal of Vascular and Endovascular Surgery. 2018; 55 (6): 757–818. DOI: https://doi.org/10.1016/j.ejvs.2018.02.001

3. Veer S.N. van der, Ravani P., Coentrão L. Barriers to adopting a fistula-first policy in Europe: an international survey among national experts. Journal of Vascular Access. 2015; 16 (2): 113–119. DOI: https://doi.org/10.5301/jva.5000313

4. Fokou M., Teyang A., Ashuntantang G., et al. Complications of arteriovenous fistula for hemodialysis: an 8-year study. Annals of Vascular Surgery. 2012; 26 (5): 680–684. DOI: https://doi.org/10.1016/j.avsg.2011.09.014

5. Valenti D. Mistry H., Stephenson M. A novel classification system for autogenous arteriovenous fistula aneurysms in renal access patients. Vascular and Endovascular Surgery. 2014; 48 (7–8): 491–496. DOI: https://doi.org/10.1177/1538574414561229

6. Nezakatgoo N., Kozusko S.D., Watson J.T., et al. A technique for the salvage of megafistulas allowing immediate dialysis access. Journal of Vascular Surgery. 2018; 68 (3): 843–848. DOI: https://doi.org/10.1016/j.jvs.2017.12.068

7. Baláž P., Rokošný S., Bafrnec J., et al. Repair of Aneurysmal Arteriovenous Fistulae: A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery. 2020; 59 (4): 614–623. DOI: https://doi.org/10.1016/j.ejvs.2019.07.033

8. Rajput A., Rajan D.K., Simons M.E. Venous aneurysms in autogenous hemodialysis fistulas: is there an association with venous outflow stenosis. Journal of Vascular Access. 2013; 14 (2): 126–130. DOI: https://doi.org/10.5301/jva.5000111

9. Watson K.R., Gallagher M., Ross R., et al. The aneurysmal arteriovenous fistula – morphological study and assessment of clinical implications. A pilot study. Vascular. 2015; 23 (5): F498–503. DOI: https://doi.org/10.1177/1708538114557069

10. Jankovic A., Donfrid B., Adam J., et al. Arteriovenous fistula aneurysm in patients on regular hemodialysis: prevalence and risk factors. Nephron. Clinical Practice. 2013; 124 (1–2): 94–98. DOI: https://doi.org/10.1159/000355548

11. Klüsch V. Aper T., Sonnenschein K., et al. A Hyperdynamic Arteriovenous Fistula Aneurysm After Long Time Renal Transplantation. Vascular and Endovascular Surgery. 2023; 2 (57): 182–185. DOI: https://doi.org/10.1177/15385744221131209

12. Stegmayr B., Willems C., Groth T., et al. Arteriovenous access in hemodialysis: A multidisciplinary perspective for future solutions. International Journal of Artificial Organs. 2021; 44 (1): 3–16. DOI: https://doi.org/10.1177/0391398820922231

13. Singh S., Sharma S. High-Output Cardiac Failure. 2023; 12. In: StatPearls Publishing, Treasure Island (FL). 2023. https://www.ncbi.nlm.nih.gov/books/NBK513337/

14. Saleh M.А., Kilany W.M.E., Keddis V.W., et al. Effect of high flow arteriovenous fistula on cardiac function in hemodialysis patients. Egyptian Heart. 2018; 70 (4): 337–341. DOI: https://doi.org/10.1016/j.ehj.2018.10.007

15. Lok C.E., Huber T.S., Lee T., et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update. American Journal of Kidney Diseases. 2020; 75 (4): S1–S164. DOI: https://doi.org/10.1053/j.ajkd.2020.05.006

16.Drouven J., Wiegersma J., Assa S., et al. Differences in shuntflow (Qa), cardiac function and mortality between hemodialysis patients with a lower-arm fistula, an upper-arm fistula, and an arteriovenous graft. Journal of Vascular Access. 2023; 24 (6): 1456–1462. DOI: https://doi.org/10.1177/11297298221092741

17.  Gerrickens M.W., Yadav R., Vaes R.H., Scheltinga M.R. A scoping review on surgical reduction of high flow arteriovenous haemodialysis access. Journal of Vascular Access. 2022; 11297298221138361. DOI: https://doi.org/10.1177/11297298221138361

18.Prastowo R., Eko Putranto J., Pratanu I., et al. Association between arteriovenous access flow and ventricular function: A cross-sectional study. Annals of Medicine and Surgery. 2022; 77: 103649. DOI: https://doi.org/10.1016/j.amsu.2022.103649

19. Grinev K.M., Karpov S.A., Alferov S.V. Non-thrombotic complications of permanent vascular access in dialysis cases and techniques for their surgical correction. Vestnik of Saint Petersburg University. Medicine. 2017; 12 (4): 340–351. DOI: https://doi.org/10.21638/11701/spbu11.2017.404 (in Russian)

20. Cahalane A.M., Sahani V.G., Irani Z., Cui J. Arterial diameter following arteriovenous fistula creation predicts aneurysm progression. Journal of Vascular Access. 2022; 23 (2): 232239. DOI: https://doi.org/10.1177/1129729820987383

  • Российское Общество ангиологов и сосудистых хирургов
  • ВКонтакте
  • Telegram
CHIEF EDITOR
CHIEF EDITOR
Yuri V. Belov
Academician of the Russian Academy of Sciences Doctor of Medical Sciences, Professor, President of the Russian Society of Angiologists and Vascular Surgeons

 

In accordance with the decision of the Presidium of the Russian Society of Angiologists and Vascular Surgeons, the journal "Angiology and Vascular Surgery" will be named after Academician A.V. Pokrovsky starting from No. 2/2022.

geotar-digit

Журналы «ГЭОТАР-Медиа»